- Home
- BEAM vs LGIH Comparison
BEAM vs LGIH Comparison
Compare BEAM & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- LGIH
- Stock Information
- Founded
- BEAM 2017
- LGIH 2003
- Country
- BEAM United States
- LGIH United States
- Employees
- BEAM N/A
- LGIH N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- LGIH Homebuilding
- Sector
- BEAM Health Care
- LGIH Consumer Discretionary
- Exchange
- BEAM Nasdaq
- LGIH Nasdaq
- Market Cap
- BEAM 1.9B
- LGIH 2.1B
- IPO Year
- BEAM 2020
- LGIH 2013
- Fundamental
- Price
- BEAM $29.01
- LGIH $91.20
- Analyst Decision
- BEAM Buy
- LGIH Hold
- Analyst Count
- BEAM 10
- LGIH 5
- Target Price
- BEAM $47.67
- LGIH $122.40
- AVG Volume (30 Days)
- BEAM 1.2M
- LGIH 221.1K
- Earning Date
- BEAM 11-05-2024
- LGIH 02-18-2025
- Dividend Yield
- BEAM N/A
- LGIH N/A
- EPS Growth
- BEAM N/A
- LGIH 9.16
- EPS
- BEAM N/A
- LGIH 8.36
- Revenue
- BEAM $349,643,000.00
- LGIH $2,253,616,000.00
- Revenue This Year
- BEAM N/A
- LGIH N/A
- Revenue Next Year
- BEAM $10.82
- LGIH $22.02
- P/E Ratio
- BEAM N/A
- LGIH $10.91
- Revenue Growth
- BEAM 328.73
- LGIH 0.68
- 52 Week Low
- BEAM $20.84
- LGIH $84.00
- 52 Week High
- BEAM $49.50
- LGIH $136.89
- Technical
- Relative Strength Index (RSI)
- BEAM 56.94
- LGIH 29.27
- Support Level
- BEAM $24.96
- LGIH $89.40
- Resistance Level
- BEAM $29.53
- LGIH $101.52
- Average True Range (ATR)
- BEAM 2.05
- LGIH 3.49
- MACD
- BEAM -0.04
- LGIH -1.72
- Stochastic Oscillator
- BEAM 67.05
- LGIH 8.72
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About LGIH LGI Homes Inc.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. They have seven operating segments ( Central, Midwest, Southeast, Mid-Atlantic, Northwest, West and Florida divisions) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.